Inflammation and dyslipidemia in nephropathy: an epidemiologic perspective.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 16408107.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The association of dyslipidemia and inflammatory markers with decreased renal function has been reported in several large epidemiologic studies. In this issue, Lin et al examine these associations among middle-aged and older type 2 diabetes, a population at high risk for chronic kidney disease. Their findings support a role for these factors in the pathogenesis of progressive renal disease.
Medical subject headings
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Dyslipidemias
- Inflammation